Frozen Tissues Samples Market Size, Share, Growth, And Industry Analysis, By Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples and Others), By Application (Cancer Research, Disease Diagnosis and Others), and Regional Forecast From 2022 to 2028

Updated On: 11 September 2023

Frozen Tissues Samples Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global frozen tissues samples market size was USD 51 million in 2021. As per our research, the market is expected to reach USD 149.4 million in 2028, exhibiting a CAGR of 16.4% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with the frozen tissues samples market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The term "frozen tissues samples" refers to biological tissue samples that have been frozen at extremely low temperatures, usually -80°C or below. Due to its ability to stop biological molecules such as DNA, RNA, and proteins from degrading, this preservation technique is frequently employed to keep tissue samples for further study or investigation. Multiple sources, including both human and animal tissues, can yield frozen tissue specimens. In order to investigate the molecular causes of disease, find biomarkers, and create novel therapies, they are frequently employed in medical research. In order to analyze particular biomarkers or mutations, tissue samples are also employed in diagnostic procedures including genetic testing and cancer profiling.

Due to the rising need for biological samples for research and the development of novel cancer and chronic disease treatments, the market for frozen tissues samples is expanding. Collecting, storing, and analyzing preserved tissue samples has become simpler and more affordable thanks to technological developments in biobanking and storage. The value of frozen samples of tissue has also grown in response to the rising need for personalized treatments and precision medicine. In the upcoming years, these elements are anticipated to continue fueling the market's expansion for frozen samples

COVID-19 Impact: Researchers Struggled to Collect Tissue Samples due to Lack of Funding for Research Programmes

First, due to lockdowns and other social isolation measures, many biobanks and research institutes were obliged to temporarily halt or scale back their operations, which interrupted the supply chain for frozen samples. The process of collecting, processing, and distributing samples was delayed as a result, which made it more challenging for researchers to obtain the samples they required for their research. Second, due to funding being diverted to COVID-19-related research as a result of the pandemic, funding for research programmes also decreased. As a result, collecting and analyzing preserved tissues samples was more difficult for researchers to do.

Latest Trends

"Better Sample Management and Retrieval is Made Possible by Biobanking Automation Technology Development"

Recent years have seen a number of advancements in the market for frozen tissue specimens, with the development of biobanking automation technology being one of the most noteworthy. These innovations make managing big collections of samples faster and more effective by automating the storage and retrieval of frozen tissues samples using robots and artificial intelligence. Overall, these developments are enhancing the effectiveness, safety, and accessibility of the tissue samples, and they are predicted to fuel continued market expansion over the next few years.

Frozen Tissues Samples Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type Analysis

According to type, the market can be segmented into frozen normal tissue samples, frozen tumor tissue samples and others.

• By Application Analysis

Based on application, the market can be divided into cancer research, disease diagnosis and others.

Driving Factors

"Growing Investments in R&D by Various Institutions will Increase the Demand for the Tissue Samples"

The frozen tissues samples market growth is expanding as a result of increased expenditure in R&D activities. The development of new medicines, treatments, and diagnostic tools is receiving significant funding from biotech and pharmaceutical companies, academic institutions, and research organizations. This work necessitates having access to high-quality biological materials, such as frozen tissue specimens. As a result, it is anticipated that demand for the tissue samples will increase during the upcoming years as the pace of research and development operations quickens.

"Growing Prevalence of Chronic Illnesses and Increasing Demand for Personalized Drugs are Driving the Market"

High-quality frozen specimens of tissue are in high demand as personalized medicine receives more attention. Access to vast, varied collections of preserved tissue samples that can be examined for genetic and other indicators is necessary for researchers working to provide individualized treatments for specific patients. Additionally, the increased incidence of chronic illnesses such as cancer and cardiovascular disease is spurring demand for frozen tissues samples. Researchers need access to high-quality tissue samples in order to better understand the pathophysiology of these diseases and create novel therapies as the prevalence of these illnesses rises.

Restraining Factors

"Legal and Ethical Difficulties Related to the Handling of the Tissues could Limit Market Expansion"

The ethical and legal concerns related to the collecting and use of human tissue samples are one of the major restraints on the frozen tissues samples industry. Concerns over patient privacy, informed permission, and ownership of biological materials are only a few of the ethical and legal problems that come up with the acquisition and use of the tissue samples. The collecting and storage of frozen tissues is also a highly regulated procedure, with stringent regulations limiting the gathering, handling, and storage of these samples. Complying with these laws can be difficult and time-consuming, and breaking them can result in penalties and legal repercussions.

Frozen Tissues Samples Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"Well-developed Biobanking Infrastructure Allow North America to Dominate the Samples Market"

Several factors are expected to allow North America to dominate the frozen tissues samples market share. First off, North America is home to several of the world's top biobanks, indicating that the area has a well-developed biobanking infrastructure. These biobanks have a significant collection of biological materials, including preserved tissue samples that are highly sought after for study. Second, the area is home to a sizable number of biopharmaceutical firms and research institutions that are actively involved in activities related to drug development. For their study, these institutions need high-quality biological samples, which is why there is a need for frozen tissue specimens in the area.

Key Industry Players

"Key Players Focus on Alliances and Acquisitions to Gain a Competitive Advantage"

Players are employing a variety of strategies to control the tissues samples sector, including alliances, mergers, and acquisitions to increase their market share and diversify their product offering. To meet the changing needs of researchers and biopharmaceutical businesses, players are also engaging in research and development operations to create new and inventive goods. For instance, BioLife Solutions declared the release of CryoStor-XF, a new cryopreservation medium intended for use in the clinical development of cell and gene treatments, in January 2021.

List of Market Players Profiled

• Precision for Medicine (U.S.)
• ProteoGenex (U.S.)
• Bay BioSciences (U.S.)
• Zen-Bio (U.S.)
• OriGene Technologies (U.S.)
• AMS Biotechnology (Europe) (U.K.)
• REPROCELL (Japan)
• US Biolab Corporation (U.S.)
• BioChain Institute (     U.S.)

Report Coverage

This report covers the frozen tissues samples market. The CAGR expected to be in during the forecast period, and also the USD value in 2021 and what it is expected to be in 2028. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.